Impact of Web Application Support Versus Standard Management on Compliance With Adjuvant Hormone Therapy at 18 Months in Patients Treated for Breast Cancer (WEBAPPAC)

Centre Francois Baclesse

Status

Enrolling

Conditions

Breast Cancer

Web-application

Hormono Therapy

Treatments

Other: WEB-Application

Other: Standard accompaniment

Study type

Interventional

Funder types

Other

Identifiers

NCT04554927

WEBAPPAC

Details and patient eligibility

About

The investigators hypothesize that the implementation of a Web-application in patients initiating adjuvant hormone therapy for breast cancer brings a benefit on treatment adherence and quality of life.

Enrollment

438 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patient > 18 years old
Breast cancer patient candidate for adjuvant hormone therapy
Mastery of the French language
Patient with a cell phone and an Internet connection
Patient able to use a computer, smartphone, or tablet.
Patient affiliated to a social security system
Signing of informed consent prior to any specific study-related procedure

Exclusion criteria

Patient who has previously received hormone therapy for cancer.
Patient not trained in the use of the application
Any associated medical or psychiatric condition that might compromise the patient's ability to participate in the study
Patients with locoregional or metastatic recurrence
Other history of cancer.
Patient deprived of liberty, under guardianship or curatorship
Simultaneous participation in a therapeutic clinical trial or other clinical study involving a connected tool
Patient unable to undergo trial follow-up for geographical, social or psychopathological reasons